Similar changes in expression and hence ratios of the BCL2 family proteins were observed in both OSU‐CLL and OSU‐CLL‐TP53ko cells following treatment with ONC‐212 (Figure 4B). This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.